Close

Maxim Group Calls Tekmira Pharma (TKMR) News 'Ground Breaking'

September 22, 2014 1:13 PM EDT Send to a Friend
Maxim Group analyst Jason Kolbert weighed in on Tekmira Pharma (NASDAQ: TKMR) after the company announced that the FDA has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login